Lineage Cell Therapeutics (LCTX) Net Margin Growth (3y) (2013 - 2026)
Lineage Cell Therapeutics (LCTX) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 267.08 Mn | 203.18 Mn | 1.73 Mn | -9,438.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,438.00 |
| Dec 31, 2025 | 24,199.00 |
| Sep 30, 2025 | -30,937.00 |
| Jun 30, 2025 | -66,605.00 |
| Mar 31, 2025 | -31,796.00 |
| Dec 31, 2024 | -5,730.00 |
| Sep 30, 2024 | 26,570.00 |
| Jun 30, 2024 | 55,971.00 |
| Mar 31, 2024 | -8,382.00 |
| Dec 31, 2023 | -50,295.00 |
| Sep 30, 2023 | 81,782.00 |
| Jun 30, 2023 | 153,038.00 |
| Mar 31, 2023 | 145,511.00 |
| Dec 31, 2022 | -102,847.00 |
| Sep 30, 2022 | 306,121.00 |
| Jun 30, 2022 | 402,511.00 |
| Mar 31, 2022 | -342,510.00 |
| Dec 31, 2021 | 592,419.00 |
| Sep 30, 2021 | -712,148.00 |
| Jun 30, 2021 | -78,732.00 |